Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;277(2):555-64.
doi: 10.1148/radiol.2015142554. Epub 2015 Jun 23.

CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds

Collaborators, Affiliations

CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds

David F Yankelevitz et al. Radiology. 2015 Nov.

Abstract

Purpose: To address the frequency of identifying nonsolid nodules, diagnosing lung cancer manifesting as such nodules, and the long-term outcome after treatment in a prospective cohort, the International Early Lung Cancer Action Program.

Materials and methods: A total of 57,496 participants underwent baseline and subsequent annual repeat computed tomographic (CT) screenings according to an institutional review board, HIPAA-compliant protocol. Informed consent was obtained. The frequency of participants with nonsolid nodules, the course of the nodule at follow-up, and the resulting diagnoses of lung cancer, treatment, and outcome are given separately for baseline and annual repeat rounds of screening. The χ(2) statistic was used to compare percentages.

Results: A nonsolid nodule was identified in 2392 (4.2%) of 57,496 baseline screenings, and pathologic pursuit led to the diagnosis of 73 cases of adenocarcinoma. A new nonsolid nodule was identified in 485 (0.7%) of 64,677 annual repeat screenings, and 11 had a diagnosis of stage I adenocarcinoma; none were in nodules 15 mm or larger in diameter. Nonsolid nodules resolved or decreased more frequently in annual repeat than in baseline rounds (322 [66%] of 485 vs 628 [26%] of 2392, P < .0001). Treatment of the cases of lung cancer was with lobectomy in 55, bilobectomy in two, sublobar resection in 26, and radiation therapy in one. Median time to treatment was 19 months (interquartile range [IQR], 6-41 months). A solid component had developed in 22 cases prior to treatment (median transition time from nonsolid to part-solid, 25 months). The lung cancer-survival rate was 100% with median follow-up since diagnosis of 78 months (IQR, 45-122 months).

Conclusion: Nonsolid nodules of any size can be safely followed with CT at 12-month intervals to assess transition to part-solid. Surgery was 100% curative in all cases, regardless of the time to treatment.

PubMed Disclaimer

Figures

Figure 1a:
Figure 1a:
CT images in a 68-year-old smoker show (a) a nonsolid nodule (17 × 13 mm) in the left upper lobe at baseline screening, (b) the nodule remained nonsolid at follow-up 2 years later, and (c) a solid component emerged at follow-up 9 years later. At that time, it was resected, and the final diagnosis was 2.1-cm invasive adenocarcinoma.
Figure 1b:
Figure 1b:
CT images in a 68-year-old smoker show (a) a nonsolid nodule (17 × 13 mm) in the left upper lobe at baseline screening, (b) the nodule remained nonsolid at follow-up 2 years later, and (c) a solid component emerged at follow-up 9 years later. At that time, it was resected, and the final diagnosis was 2.1-cm invasive adenocarcinoma.
Figure 1c:
Figure 1c:
CT images in a 68-year-old smoker show (a) a nonsolid nodule (17 × 13 mm) in the left upper lobe at baseline screening, (b) the nodule remained nonsolid at follow-up 2 years later, and (c) a solid component emerged at follow-up 9 years later. At that time, it was resected, and the final diagnosis was 2.1-cm invasive adenocarcinoma.
Figure 2:
Figure 2:
Graph shows the likelihood of diagnosing a lung cancer manifesting in a nonsolid nodule, separately in the baseline (blue) and annual repeat (red) rounds of CT screening.

Comment in

References

    1. Kitamura H, Kameda Y, Nakamura N, et al. . Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 1996;20(5):553–562. - PubMed
    1. Wang JC, Sone S, Feng L, et al. . Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features. Br J Radiol 2000;73(873):930–937. - PubMed
    1. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. . CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178(5):1053–1057. - PubMed
    1. Henschke CI, Shaham D, Yankelevitz DF, et al. . CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin Imaging 2006;30(1):11–15. - PubMed
    1. Vazquez M, Carter D, Brambilla E, et al. . Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009;64(2):148–154. - PMC - PubMed

Publication types